Kerendia 10 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FXHN8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,179
Award facts
- Contract value 100% obligated
- $32,178.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on May 8, 2025, represents a $32,178.58 firm fixed price purchase of Kerendia 10 mg tablets (30-count units) from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The Defense Logistics Agency, under the Department of Defense, issued this non-competitive set-aside award to support federal medical procurement needs. The contract performance location is based in Conshohocken, PA, with an ultimate completion date of May 9, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026.
The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Kerendia (finerenone) is a non-steroidal mineralocorticoid receptor antagonist used primarily for treating chronic kidney disease and heart failure in patients with type 2 diabetes. This delivery order reflects AmerisourceBergen's critical role as a strategic pharmaceutical prime vendor within the Defense Logistics Agency's medical supply chain, fulfilling ongoing demand for specialized medications supporting military personnel and veteran healthcare initiatives.
Quick answers
Who was awarded contract SPE2DB25FXHN8?
SPE2DB25FXHN8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 8, 2025.
How much is contract SPE2DB25FXHN8 worth?
The government has obligated $32,179 on SPE2DB25FXHN8.
Is contract SPE2DB25FXHN8 an order under another contract?
Yes. SPE2DB25FXHN8 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB25FXHN8 competed?
The extent of competition for SPE2DB25FXHN8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award